3Li Dexin.Selective head cooling-dehydration combined therapy for heain resuscitation[M].3rd.Japan Fukuoka:Japanese-Chinese Anesthesiolohy Congress,1993:14.
二级参考文献13
1Hebert PC, Wells G, Blajchman MA, et al. Amulticenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med, 1999,340:409-417.
2Hebert PC,Yetisir E,Martin C,et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med, 2001,29: 227-234.
3Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA, 2002,288:1499-1507.
4Isbister JP. Is the clinical significance of blood storage lesions underestimated? TATM, 2003,5: 356-362.
5Gan TJ. Intraoperative fluid management and choice of fluid. ASA 54th Ann Refresher Course Lectures, San Francisco, 2003. 236.
6McIlroy DR,Kharasch ED. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg,2003,96:1572-1577.
7Friedman Z,Berkenstadt H,Preisman S,et al. A Comparison of lactated Ringer' s solution to hydroxyethy starch 6 % in a model of severe hemorrhagic shock and continuous bleeding in dogs. Anesth Analg, 2003,96:39-45.
8Lang K,Boldt J,Suttner S,et al. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg, 2001,93: 405-409.
9Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients:Systematic review of randomized controlled trials. BMJ, 1998,317:235-240.
10Jungheinrich C, Scharpf R, Wargenau M, et al. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0. 4 (6%,500ml) in mild-to-servere renal impairment. Anesth Analg, 2002,95: 544-551.
